Price $150.16 |
Market Cap
13.11B
|
Sector Health Care |
Div. Growth
9.00%
|
|
P/E
32.4
|
P/B
3.85
|
P/S
4.31
|
Dividend %
1.00%
|
|
P/CF
133.3
|
P/FCF
52.1
|
Op. Cash Flow
590.6K
|
FCF
2.9
|
|
Op. Margin
17.70%
|
Net Margin
13.40%
|
ROE
12.30%
|
ROI
9.80%
|
|
ROA
7.70%
|
EPS Growth
33.70%
|
Current Ratio
2.4
|
Debt/Equity
33.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| American Bio Medica Corporatio (ABMC) | $1.18 | - | - | 37.3M | Strong Buy |
| Americann Inc (ACAN) | $0.59 | - | - | 13.5M | Strong Buy |
| Endo International PLC (ENDP) | $3.37 | - | - | 806.3M | Strong Buy |
| Pacific Biosciences of Califor (PACB) | $3.79 | - | - | 556.3M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.67 | - | - | 1.39B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
